Trent Fowler

Trent Fowler has a diverse work experience, starting with their role as Operations Manager at PEEL Therapeutics from September 2016 to March 2019. During this time, they effectively managed company finances, generated budgets, and analyzed industry trends to guide company valuation. Trent also played a crucial role in procuring lab equipment and contributed to investor pitch presentations, resulting in over $10M in funding.

Following this, Trent joined PEEL Therapeutics as the Director of Operations in March 2019, a position they held until February 2022. In this role, they collaborated with executive leadership to set and execute strategic priorities. Trent oversaw manufacturing campaigns for pre-clinical studies, developed partnerships with contract research organizations, and managed contracts and intellectual property portfolio. Trent also championed the use of project management and communication tools to improve firmwide communication and productivity.

Since July 2021, Trent has taken on the role of Vice President Operations at PEEL Therapeutics, where they continue to contribute to the strategic direction of the firm without a specified end date.

Prior to their time at PEEL Therapeutics, Trent worked as a Clinical Research Coordinator and Lab Manager at Huntsman Cancer Institute from February 2013 to December 2017. Trent also served as a Clinical Research Coordinator at Pacific Neuroscience Medical Group from May 2011 to December 2012.

Trent Fowler pursued higher education starting in 2007, when they attended Westmont College. Trent successfully completed their Bachelor of Science in Psychology in 2011. After that, they pursued further studies and enrolled at the University of Utah from 2013 to 2015, specializing in Pre-Medicine/Pre-Medical Studies. However, it is not specified whether they obtained a degree during this period. Their education journey continued at Northwestern University - Kellogg School of Management, where they pursued a Master of Business Administration (M.B.A.) with a focus on Finance and Strategy from 2016 to 2019.